Public Employees Retirement System Of Ohio Tango Therapeutics, Inc. Transaction History

Public Employees Retirement System Of Ohio

$22.6 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Dec 19, 2023	BUY	$3.41 - $8.29 $82,262 - $199,987	24,124 New	24,124 $174,000
Q4 2022 Feb 15, 2023	SELL	$3.41 - $8.29 $18,673 - $45,396	-5,476 Reduced 18.5%	24,124 $175,000
Q3 2022 Nov 15, 2022	BUY	$3.25 - $5.46 $96,200 - $161,616	29,600 New	29,600 $107,000

Others Institutions Holding TNGX

# of Institutions

123

Shares Held

91.7M

Call Options Held

3.1K

Put Options Held

1.5K

Trv Gp Iv, LLC Boston, MA

16.9M
Shares

$68.8 Million
80.09% of portfolio
Eco R1 Capital, LLC San Francisco, CA

13.3M
Shares

$54.4 Million
4.45% of portfolio
Boxer Capital, LLC San Diego, CA

8.2M
Shares

$33.5 Million
3.35% of portfolio
Nextech Invest Ag

5.53M
Shares

$22.6 Million
6.95% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.02M
Shares

$20.5 Million
0.02% of portfolio

View Full List

About Tango Therapeutics, Inc.

Ticker TNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,067,296
Market Cap $359M
Description
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...

More about TNGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.

Account